Regeneron Pharmaceuticals reported $59.5B in Market Capitalization for its second fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Market Capitalization Change
Abbvie ABBV:US $ 198.95B 7.96B
Acceleron Pharma XLRN:US $ 7.62B 606.02M
Agenus AGEN:US $ 1.22B 664.46M
Agios Pharmaceuticals AGIO:US $ 3.39B 211.72M
Alexion Pharmaceuticals ALXN:US $ 33.78B 393.15M
Alimera Sciences ALIM:US $ 62.78M 7.43M
Alnylam Pharmaceuticals ALNY:US $ 19.93B 3.36B
Amgen AMGN:US $ 140.05B 3.22B
Astellas Pharma 4503:JP 3601.63B 432.87B
AstraZeneca AZN:LN 113.99B 18.86B
Biogen BIIB:US $ 52.13B 9.52B
Biomarin Pharmaceutical BMRN:US $ 15.25B 1.45B
Bluebird Bio BLUE:US $ 2.16B 132.67M
Bristol Myers Squibb BMY:US $ 148.48B 7.52B
Eli Lilly And LLY:US $ 220.12B 40.96B
Esperion Therapeutics ESPR:US $ 596.26M 193.51M
Gilead Sciences GILD:US $ 86.36B 4.99B
GlaxoSmithKline GSK:LN 71.42B 6.62B
Intercept Pharmaceuticals ICPT:US $ 663.03M 98.97M
IONIS PHARMACEUT IONS:US $ 5.62B 710.4M
Johnson & Johnson JNJ:US $ 433825.66M 1140.33M
Kyowa Hakko Kirin 4151:JP 2127.6B 340.2B
Merk MRK:US $ 196918.18M 1780.24M
Moderna Inc MRNA:US $ 94.35B 41.95B
Neurocrine Biosciences NBIX:US $ 9.2B 7.62M
Novartis NOVN:VX 208.02B 8.76B
Novartis NVS:US 224.91B 13.69B
Ophthotech OPHT:US $ 569.51M 12.26M
Opthea Ltd OPT:AU 469.4M 178.91M
Pfizer PFE:US $ 219205.69M 17108.81M
Puma Biotechnology PBYI:US $ 370.52M 20.79M
Regeneron Pharmaceuticals REGN:US $ 59.5B 8.81B
Sanofi SNY:US 132.07B 7.67B
Sarepta Therapeutics SRPT:US $ 6.2B 282.45M
Seattle Genetics SGEN:US $ 28.65B 3.48B
Teva Pharmaceutical TEVA:IT 35.79B 6.09B
Ultragenyx Pharmaceutical RARE:US $ 6.43B 1.19B
United Therapeutics UTHR:US $ 8.04B 550.55M
Vertex Pharmaceuticals VRTX:US $ 52.2B 3.42B
YTE INCY:US $ 18.5B 632.77M